UK MHRA approves Vazkepa to reduce the risk of cardiovascular events – Amarin Corp
Amarin Corporation announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a Great Britain Marketing Authorisation for Vazkepa (icosapent ethyl) as a treatment to reduce… read more.